Učitavanje...

A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen

Development of nasal immunization for human use is hindered by the lack of acceptable adjuvants. Although CT is an effective adjuvant, its toxicity will likely prevent its use in nasal vaccines. This study compared non-toxin adjuvants to CT for their ability to induce protective antibody responses w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Gwinn, William M., Johnson, Brandi T., Kirwan, Shaun M., Sobel, Ashley E., Abraham, Soman N., Gunn, Michael D., Staats, Herman F.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3622208/
https://ncbi.nlm.nih.gov/pubmed/23352329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.01.012
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!